Pericarditis
Also known as: Pericardial Inflammation, Heart Sac Inflammation, Acute Pericarditis
Pericarditis is inflammation of the pericardium, the thin two-layered sac surrounding the heart, causing sharp chest pain that often worsens with deep breathing, lying flat, or coughing. The condition is most commonly caused by viral infections, but can also result from bacterial infections, autoimmune diseases, heart attack, cardiac surgery, or kidney failure. While most cases of acute pericarditis resolve within a few weeks with anti-inflammatory treatment, some patients develop complications such as pericardial effusion (fluid accumulation) or chronic/recurrent pericarditis.
Last updated November 10, 2026
Understanding Pericarditis
Pericarditis is inflammation of the pericardium, the thin double-layered sac that holds the heart and normally contains 15 to 50 mL of lubricating fluid. Acute pericarditis is the most common pericardial disease: it accounts for about 5 percent of emergency department visits for chest pain that turn out not to be a heart attack and roughly 0.1 percent of hospital admissions, with an incidence of about 28 cases per 100,000 people a year in the best population study. Men between 20 and 50 are affected most often. In North America and Europe, 80 to 90 percent of cases are labeled idiopathic because no cause is found, and most of those are presumed viral; tuberculosis is the leading cause in much of the world. The diagnosis needs two of four findings: the typical sharp, positional chest pain, a scratching friction rub on examination, the characteristic widespread ST elevation or PR depression on the ECG, and new or worsening fluid around the heart on echocardiography.
The two layers of the pericardium become inflamed and rub against each other, which is why the pain is sharp, worse lying flat or breathing in, and better leaning forward. C-reactive protein is raised in about three quarters of people at presentation and is the most useful marker for tracking recovery. In up to a third, inflammation spills into the heart muscle beneath and troponin rises, a pattern called myopericarditis; it usually recovers fully but earns a longer break from exercise. Most viral or idiopathic episodes settle within one to three weeks on treatment. The main problem is recurrence: 15 to 30 percent of people have a second episode, usually within 18 months, and about half of those go on to a third without colchicine. Large effusions and cardiac tamponade, where fluid compresses the heart, occur in a small minority and are more likely when the cause is bacterial, cancer or autoimmune. Constrictive pericarditis, a scarred and stiffened sac, follows under 1 percent of viral cases but 20 to 30 percent of bacterial ones.
Treatment follows the 2015 European Society of Cardiology pericardial disease guideline, which US cardiologists also use. First line is a full-dose NSAID, typically ibuprofen 600 mg or aspirin 750 to 1,000 mg three times daily for one to two weeks, then tapered, with stomach protection. The second drug is colchicine, and the evidence for it is unusually clean. In the ICAP trial of 240 people with a first episode, adding 0.5 mg of colchicine once or twice daily for three months cut recurrence at 18 months from 37.5 to 16.7 percent; COPE and CORP showed the same halving, and CORP-2 extended it to people with multiple recurrences (42.5 versus 21.6 percent). Corticosteroids relieve pain but roughly double the chance of recurrence and are reserved for people who cannot take NSAIDs, are pregnant, or have an autoimmune cause, and then at low dose. For the small group with colchicine-resistant recurrent disease, the interleukin-1 blocker rilonacept reduced recurrence from 74 to 7 percent in the 2021 RHAPSODY trial, and anakinra had similar results in the smaller AIRTRIP trial.
There is no supplement, herb or diet with a trial in pericarditis, and it would be dishonest to pretend otherwise. Colchicine itself comes from the autumn crocus, but the plant is lethal in unmeasured amounts and the purified drug is the only safe form. Omega-3 fatty acids and curcumin both lower C-reactive protein modestly in meta-analyses of other inflammatory conditions, which is a reason to consider them as low-risk adjuncts rather than a reason to expect them to treat an inflamed pericardium; neither has been tested here, and neither should delay or replace an NSAID and colchicine. Products promoted for heart inflammation, including high-dose vitamin C, nattokinase and serrapeptase, have no data in pericarditis, and anything that thins the blood is unwise when a pericardial effusion is present, because bleeding into the sac can precipitate tamponade. The most valuable non-drug measure is rest from exertion, and it has specific numbers attached, described below.
The most common mistake is stopping too early. People feel better within days on an NSAID and quietly drop it, or stop colchicine when the diarrhea starts, and then relapse four weeks later. The NSAID should run at full dose until symptoms are gone and CRP has normalized, then be tapered; colchicine continues for the full three months after a first episode and six months after a recurrence, and dropping to once daily usually settles the bowel. The second mistake is returning to sport too soon. Exertion raises heart rate and pericardial shear and is the best-documented trigger of relapse, so the guideline restricts exercise until symptoms resolve and CRP is normal for non-athletes, and for at least three months in competitive athletes, longer if the heart muscle was involved. The third mistake is reaching for prednisone because it works fastest; it also makes the illness most likely to come back.
At a Glance
- Common symptoms
- Sharp, stabbing chest pain, often on the left side or behind the breastbone, Pain that worsens when lying down, coughing, or taking deep breaths, Pain that improves when sitting up and leaning forward
- Main treatments
- NSAIDs (ibuprofen, aspirin) as first-line anti-inflammatory therapy, Colchicine to reduce inflammation and prevent recurrence, Corticosteroids for NSAID-refractory or autoimmune-related pericarditis
- Category
- Cardiovascular · Accounts for approximately 5% of emergency department visits for chest pain
- See a doctor if
- You experience sharp chest pain, especially with breathing or position changes
Symptoms
Causes
- Viral infections (Coxsackie virus, echovirus, adenovirus, COVID-19)
- Autoimmune and inflammatory conditions (lupus, rheumatoid arthritis, sarcoidosis)
- Post-myocardial infarction (Dressler syndrome) or post-cardiac surgery
- Bacterial, fungal, or tuberculous pericardial infection
- Uremia (kidney failure) causing metabolic pericarditis
- Cancer metastasis to the pericardium
Risk Factors
- Recent viral upper respiratory infection
- History of heart attack or cardiac surgery
- Autoimmune or inflammatory conditions
- Advanced kidney disease requiring dialysis
- Male sex (more commonly diagnosed in men aged 20-50)
- Previous episode of pericarditis (risk of recurrence)
Diagnosis
- Electrocardiogram (ECG) showing characteristic diffuse ST-segment elevation
- Echocardiogram to detect pericardial effusion and assess heart function
- Blood tests including inflammatory markers (CRP, ESR), troponin, and CBC
- Chest X-ray to evaluate heart size and rule out other conditions
- CT or MRI for complicated or recurrent cases
Treatment
- NSAIDs (ibuprofen, aspirin) as first-line anti-inflammatory therapy
- Colchicine to reduce inflammation and prevent recurrence
- Corticosteroids for NSAID-refractory or autoimmune-related pericarditis
- Pericardiocentesis (needle drainage) for large or hemodynamically significant effusions
- Interleukin-1 receptor antagonists (anakinra, rilonacept) for recurrent pericarditis
- Pericardiectomy (surgical removal of the pericardium) for chronic constrictive pericarditis
Natural remedies for pericarditis: what the evidence says
Ranked by the strength of human evidence for pericarditis specifically. These sit alongside medical care, not in place of it.
Omega-3
Preliminary evidenceNo trial of fish oil exists in pericarditis. The rationale is indirect: a 2021 meta-analysis of 38 randomized trials found EPA and DHA lowered C-reactive protein by a small but consistent amount, and omega-3s reduced inflammatory markers after cardiac surgery in some trials, though they did not reliably prevent post-operative atrial fibrillation in the 1,516-person OPERA trial. Treat it as a low-risk adjunct for general cardiovascular health, not as a treatment for the inflamed pericardium.
- Studied dose
- 1 to 2 g combined EPA and DHA daily from fish oil or krill oil, taken with food.
- Cautions
- Mild blood-thinning effect; tell your cardiologist if you have a pericardial effusion or take aspirin, warfarin or a DOAC. Doses above 3 g daily have been linked to atrial fibrillation in trial meta-analyses.
Curcumin
Preliminary evidenceCurcumin has not been studied in pericarditis. In a 2019 meta-analysis of 32 randomized trials in other inflammatory conditions, it lowered CRP and interleukin-6 modestly, and animal studies show reduced myocardial inflammation. That is enough to call it plausible and no more; it should never substitute for the NSAID and colchicine that have actual trial evidence.
- Studied dose
- 500 mg of a bioavailable curcumin extract (with piperine or in a phospholipid complex) once or twice daily with food.
- Cautions
- Adds to the bleeding tendency of NSAIDs and anticoagulants, which matters with an effusion. Piperine-containing products raise levels of many drugs; rare liver injury has been reported with high-dose extracts.
What matters day to day
- Stop strenuous exercise until your symptoms have gone and your CRP is normal, which takes 2 to 4 weeks for most non-athletes; competitive athletes need at least 3 months, and 3 to 6 months if troponin was raised, because exertion is the best-documented trigger of relapse.
- Take your NSAID with food and ask about a proton pump inhibitor, especially if you are over 65 or also on aspirin: two weeks of high-dose ibuprofen or aspirin carries a real gastrointestinal bleeding risk that a PPI reduces by about half.
- Avoid grapefruit juice while on colchicine and tell your doctor about every other medicine, particularly clarithromycin, certain statins, verapamil and diltiazem: these block the enzymes that clear colchicine and have caused fatal toxicity.
- Sleep propped up on two or three pillows or in a recliner for the first week: lying flat stretches the inflamed sac and is why the pain is worst at night.
- Ask for a CRP at diagnosis and every 1 to 2 weeks until it is normal: it tells you and your cardiologist when the NSAID can be tapered and when exercise is safe, better than how you feel.
- Keep alcohol to a minimum during the NSAID course: it multiplies the stomach-bleeding risk and dehydrates, and dehydration increases colchicine toxicity.
Prevention
- No specific prevention for idiopathic or viral pericarditis
- Take colchicine as prescribed to prevent recurrence after initial episode
- Manage underlying autoimmune or inflammatory conditions
- Avoid vigorous exercise during active pericarditis to prevent complications
- Follow up regularly with a cardiologist after an episode of pericarditis
When to See a Doctor
- You experience sharp chest pain, especially with breathing or position changes
- Chest pain is severe, new, or different from any previous episodes
- You develop shortness of breath, fever, or leg swelling with chest pain
- You have had pericarditis before and symptoms are recurring
Frequently Asked Questions
References
- Adler Y, Charron P, Imazio M, et al.. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases. European Heart Journal (2015)
- Imazio M, Brucato A, Cemin R, et al.. A randomized trial of colchicine for acute pericarditis (ICAP). New England Journal of Medicine (2013)
- Imazio M, Bobbio M, Cecchi E, et al.. Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation (2005)
- Imazio M, Belli R, Brucato A, et al.. Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial. Lancet (2014)
- Klein AL, Imazio M, Cremer P, et al.. Phase 3 trial of interleukin-1 trap rilonacept in recurrent pericarditis (RHAPSODY). New England Journal of Medicine (2021)
- Brucato A, Imazio M, Gattorno M, et al.. Effect of anakinra on recurrent pericarditis among patients with colchicine resistance and corticosteroid dependence: the AIRTRIP randomized clinical trial. JAMA (2016)
- Chiabrando JG, Bonaventura A, Vecchie A, et al.. Management of acute and recurrent pericarditis: JACC state-of-the-art review. Journal of the American College of Cardiology (2020)
- Mayo Clinic. Pericarditis: Symptoms and causes (2024)View source
- MedlinePlus, National Library of Medicine. Pericardial Disorders (2024)View source
Related Conditions
Lab tests that relate to pericarditis
Have questions about Pericarditis?
Ask Mother Nature AI for personalized, evidence-based guidance.
Medical Disclaimer: This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider.
Content reviewed against peer-reviewed medical literature and clinical guidelines. Read our editorial standards.